Treatment with systemic immunosuppressive medications
Use of systemic corticosteroids or other systemic immunosuppressive drugs
Concurrent medical condition requiring the use of immunosuppressive medications, or immunosuppressive doses of systemic or absorbable topical corticosteroids except inhaled or intranasal corticosteroids (with minimal systemic absorption)
No addition or subtraction of other immunosuppressive medications for at least  weeks prior to starting treatment
Treatment with systemic immunosuppressive medications within  weeks prior to initiation of study treatment or anticipation of need for systemic immunosuppressive medications during the study
Treatment with systemic corticosteroids or other systemic immunosuppressive medications within  weeks prior to randomization, or anticipated requirement for systemic immunosuppressive medications during the trial Cardiac Exclusion Criteria
Treatment with systemic immunosuppressive medications within  weeks prior to Day , Cycle  Exclusions Related to Other Medical Conditions or Medications
Patients with a condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications within  days of study entry are ineligible
Treatment with systemic corticosteroids or other systemic immunosuppressive medications within  weeks prior to randomisation, or anticipated requirement for systemic immunosuppressive medications during the trial Exclusion Criteria Related to Capecitabine:
No immunosuppressive medications except non-systemic corticosteroids
Able to be off prednisone or other immunosuppressive medications for at least  days prior to FATE-NK cell infusion (excluding preparative regimen premedications)
Use of corticosteroids or other immunosuppressive medications per exclusion criteria
Able to be off prednisone or other immunosuppressive medications for at least  days prior to FATE-NK cell infusion (excluding preparative regimen pre-medications)
Able to be off prednisone or other systemic immunosuppressive medications for at least  days prior to NK cell infusion (excluding preparative regimen pre-medications)
Able to be off prednisone or other immunosuppressive medications for at least  days prior to NAM-NK cell infusion (excluding preparative regimen pre-medications)
Patients with conditions requiring high doses of steroids or other immunosuppressive medications are excluded.
Subjects must be off of all immunosuppressive medications for a minimum of  weeks with the exception of physiologic doses of corticosteroids
Concurrent medical condition requiring the use of immunosuppressive medications, or systemic steroids; topical corticosteroids are allowed
Patients with a condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications.
Subjects requiring systemic treatment with corticosteroids or other immunosuppressive medications within  days prior to the first treatment.
Concurrent medical condition requiring the use of systemic immunosuppressive treatment within  days before the first dose of study treatment.
Use of immunosuppressive medications within  weeks or systemic corticosteroids within  weeks prior to study treatment.
Treatment with systemic corticosteroids or other systemic immunosuppressive medications within  weeks prior to Day  of Cycle , or anticipated requirement for systemic immunosuppressive medications during the trial
Have significant immunosuppression from concurrent, recent, or anticipated need for chronic treatment with systemic immunosuppressive dose of corticosteroids or immunosuppressive medications.
Able to be off prednisone or other immunosuppressive medications for at least  days prior to transplant (excluding preparative regimen premedications)
Condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications within  day of study drug administration
Patients who are taking immunosuppressive medications that cannot be discontinued (corticosteroids); patients who have discontinued immunosuppressive medications but be at least  week post their last dose
Able to be off prednisone or other immunosuppressive medications other than that prescribed per protocol for at least  days prior to day 
Able to be off prednisone or other immunosuppressive medications for at least  days prior to NK cell infusion (excluding preparative regimen pre-medications)
Concurrent therapy with systemic corticosteroids or other immunosuppressive medications
Concurrent medical condition requiring the use of immunosuppressive medications or immunosuppressive doses of systemic or absorbable topical corticosteroids
Concurrent medical condition requiring the use of immunosuppressive medications, or immunosuppressive doses of systemic or absorbable topical corticosteroids
Subjects with a condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications within  days of study drug administration
Use of immunosuppressive medications within  weeks or systemic corticosteroids within  weeks prior to first dose of study treatment.
Immunosuppressive regimens involving systemic corticosteroids within  days before the first dose of study treatment.
Treatment with systemic immunosuppressive medications within  weeks prior to first dosing (inhaled corticosteroids and mineralocorticoids are allowed).
Treatment with systemic corticosteroids or other systemic immunosuppressive medications within  weeks prior to randomization, or anticipated requirement for systemic immunosuppressive medications during the trial
Treatment with systemic immunosuppressive medications
Concurrent medical condition requiring the use of immunosuppressive medications, or immunosuppressive doses of systemic or absorbable topical corticosteroids
Treatment with systemic corticosteroids or other systemic immunosuppressive medications within  weeks prior to enrollment
Use of corticosteroids or other immunosuppressive medications
Systemic treatment with corticosteriods or other immunosuppressive medications within  days of study drug administration
Use of corticosteroids or other immunosuppressive medications
Subjects with a condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications within  days of randomization
Able to be off prednisone or other immunosuppressive medications for at least  days prior to NK cell infusion (excluding preparative regimen pre-medications)
Able to be off prednisone or other immunosuppressive medications for at least  days prior to NK cell infusion (except for those prescribed as part of the study)
Use of immunosuppressive medications within  weeks or systemic corticosteroids within  weeks prior to first dose of study treatment.
Subjects with any condition requiring systemic corticosteroids, cytotoxic therapy or immunosuppressive medications
Use of immunosuppressive medications within  weeks or systemic corticosteroids within  weeks prior to first dose of study treatment.
Treatment with systemic immunosuppressive medications within  weeks prior to the first dose of study treatment, or anticipated requirement for systemic immunosuppressive medications during the trial
Patients with a condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications
Participant has not taken immunosuppressive medications for at least  weeks
Treatment with systemic immunosuppressive medications within  weeks prior to Cycle , Day 
Immunosuppressive medications or immunosuppressive doses of systemic corticosteroids
Treatment with systemic corticosteroids or other immunosuppressive medications within  weeks prior to Cycle , Day 
Treatment with systemic immunosuppressive medications - Pregnant or lactating women
Patients regularly use steroid or other immunosuppressive medications
Patients with steroid refractory chronic GVHD must be on stable doses of corticosteroids and other immunosuppressive medications for  weeks prior to enrollment
Treatment with systemic immunosuppressive medications within  weeks prior to first day of study treatment (inhaled corticosteroids and mineralocorticoids allowed)
Has a condition requiring systemic treatment with either corticosteroids or other immunosuppressive medications within  days of study drug administration.
